Literature DB >> 16302765

Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions.

Shengmin Sang1, Mao-Jung Lee, Zhe Hou, Chi-Tang Ho, Chung S Yang.   

Abstract

(-)-Epigallocatechin-3-gallate (EGCG), the most abundant and biologically active compound in tea, has been extensively studied for its activities related to disease prevention in animal models and in vitro. However, its stability under different experimental conditions has not been well-characterized. In the present study, the stability of EGCG in animal drinking fluid and under cell culture conditions and the factors that affect its stability under these conditions were investigated. Our results demonstrated that auto-oxidation and epimerization are the two major reactions causing the instability of EGCG. The structures of the major oxidation products, EGCG dimers, were identified. The rates of these reactions were affected by the temperature, pH, the partial pressure of oxygen, the level of antioxidants, the concentration of EGCG, and other components of tea. In future studies with EGCG, its stability should be considered in order to avoid possible artifacts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16302765     DOI: 10.1021/jf0519055

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  77 in total

1.  Digallate dimers of (-)-epigallocatechin gallate inactivate herpes simplex virus.

Authors:  Charles E Isaacs; Weimin Xu; George Merz; Sharon Hillier; Lisa Rohan; Guang Y Wen
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

2.  Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages.

Authors:  Jia Zhang; Shufang Nie; Shu Wang
Journal:  J Agric Food Chem       Date:  2013-09-10       Impact factor: 5.279

3.  Synthesis and structure-activity relationships of EGCG analogues, a recently identified Hsp90 inhibitor.

Authors:  Anuj Khandelwal; Jessica A Hall; Brian S J Blagg
Journal:  J Org Chem       Date:  2013-08-01       Impact factor: 4.354

4.  Green tea polyphenols control dysregulated glutamate dehydrogenase in transgenic mice by hijacking the ADP activation site.

Authors:  Changhong Li; Ming Li; Pan Chen; Srinivas Narayan; Franz M Matschinsky; Michael J Bennett; Charles A Stanley; Thomas J Smith
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

5.  Green tea polyphenol extract in vivo attenuates inflammatory features of neutrophils from obese rats.

Authors:  K F F S Albuquerque; M P Marinovic; A C Morandi; A P Bolin; R Otton
Journal:  Eur J Nutr       Date:  2015-06-02       Impact factor: 5.614

6.  Nanoscale inhibition of polymorphic and ambidextrous IAPP amyloid aggregation with small molecules.

Authors:  Aleksandr Kakinen; Jozef Adamcik; Bo Wang; Xinwei Ge; Raffaele Mezzenga; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Nano Res       Date:  2018-08-02       Impact factor: 8.897

7.  N-Acetylcysteine enhances the lung cancer inhibitory effect of epigallocatechin-3-gallate and forms a new adduct.

Authors:  Joshua D Lambert; Shengmin Sang; Chung S Yang
Journal:  Free Radic Biol Med       Date:  2007-12-23       Impact factor: 7.376

Review 8.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

9.  Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils.

Authors:  Fernando L Palhano; Jiyong Lee; Neil P Grimster; Jeffery W Kelly
Journal:  J Am Chem Soc       Date:  2013-05-07       Impact factor: 15.419

10.  Vitamin A enhances antitumor effect of a green tea polyphenol on melanoma by upregulating the polyphenol sensing molecule 67-kDa laminin receptor.

Authors:  Ju Hye Lee; Mutsumi Kishikawa; Motofumi Kumazoe; Koji Yamada; Hirofumi Tachibana
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.